Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C11H12Cl2N2O.ClH |
| Molecular Weight | 295.593 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C[C@H](OC1=C(Cl)C=CC=C1Cl)C2=NCCN2
InChI
InChIKey=DWWHMKBNNNZGHF-FJXQXJEOSA-N
InChI=1S/C11H12Cl2N2O.ClH/c1-7(11-14-5-6-15-11)16-10-8(12)3-2-4-9(10)13;/h2-4,7H,5-6H2,1H3,(H,14,15);1H/t7-;/m0./s1
| Molecular Formula | C11H12Cl2N2O |
| Molecular Weight | 259.132 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2879913
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2879913
Dexlofexidine is an isomer “+“ of lofexidine, which is agonist of alpha 2-adrenoceptor, but in 10 times less potent than the other isomer, levlofexidine.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095158 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2879913 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pharmacokinetics of lofexidine hydrochloride in healthy volunteers. | 2009-01 |
|
| Two stereoisomeric imidazoline derivatives: synthesis and optical and alpha 2-adrenoceptor activities. | 1986-07 |
|
| Interference of enantiomers of lofexidine with alpha-adrenoceptors. | 1985-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2988468
in rats
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:41:19 GMT 2025
by
admin
on
Mon Mar 31 23:41:19 GMT 2025
|
| Record UNII |
56H4BIV8OG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
45279768
Created by
admin on Mon Mar 31 23:41:19 GMT 2025 , Edited by admin on Mon Mar 31 23:41:19 GMT 2025
|
PRIMARY | |||
|
56H4BIV8OG
Created by
admin on Mon Mar 31 23:41:19 GMT 2025 , Edited by admin on Mon Mar 31 23:41:19 GMT 2025
|
PRIMARY | |||
|
87858-98-8
Created by
admin on Mon Mar 31 23:41:19 GMT 2025 , Edited by admin on Mon Mar 31 23:41:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER | |||
|
|
PARENT -> SALT/SOLVATE |